Skip to main content

mHealth market to Reach USD 176.69 Billion by 2031, Growing at 13.8% CAGR | SkyQuest Technology

Westford, USA, Aug. 09, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that Global mHealth Market will attain a value of USD 176.69 Billion by 2031, with a CAGR of 13.8% over the forecast period (2024-2031). There will be a significant increase in the global market over the next few years. It is expected that the market will grow rapidly in years ahead due to factors such as rising demand for smartphones, tablets as well as other kinds of mobile platforms; use of connected devices and mHealth applications to treat and keep track of chronic diseases. The need to contain costs in the delivery of healthcare; the widespread adoption of 3G and 4G networks; the growing emphasis on patient-centric healthcare delivery; and the rise in demand for home healthcare services.
Download a detailed overview:
https://www.skyquestt.com/sample-request/mhealth-market
Browse in-depth TOC on the ” mHealth Market “

  • Pages – 157
  • Tables – 92
  • Figures – 76

mHealth Market Overview:

Report CoverageDetails
Market Revenue in 2023$62.82 Billion
Estimated Value by 2031$176.69 Billion
Growth RatePoised to grow at a CAGR of 13.8%
Forecast Period2024–2031
Forecast UnitsValue (USD Billion)
 Report CoverageRevenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments CoveredComponent, and End Use
Geographies CoveredNorth America, Europe, Asia Pacific, Middle East & Africa, Latin America
Report HighlightsRevolutionizing healthcare with AI, data analytics, and 5G in mHealth
Key Market OpportunitiesGrowing adoption of mHealth solutions in other mobile platforms
Key Market DriversGrowing penetration of 4G & 5G networks to ensure uninterrupted healthcare


Mobile Health Apps Product to Dominate Due to Convenient Access to Medical Information

Smartphone usage and health consciousness are on the rise creating a population of smartphone health users thus making mobile health applications leaders of the global mHealth market. Such applications provide remote monitoring, personalized health management, and instant access to medical information thus increasing patient involvement and compliance leading to high adoption rates and expansion of the market.

Remote Monitoring Service to be the Largest Growing Sub-Segment Due to Advances in Wearable Technology

The global mHealth industry is led by remote monitoring services due to wearable technological advancements and an increase in the prevalence of chronic diseases. These solutions improve results and reduce hospital visits through continuous patient monitoring and early detection of health complications, thereby enhancing patients’ convenience and healthcare productivity to drive their wide acceptance and dominance.

Favorable Government Initiatives Helped North America to Dominate the Market

North America was the highest revenue earning region for the global mHealth market in 2021 due to several reasons such as its advanced network infrastructure, increasing elderly people, increasing costs on health and increasing rates of chronic diseases. Additionally, there are beneficial government policies and increasing use of mobile healthcare apps that are also pushing up demand for mHealth services within the same zone.
Request Free Customization of this report:
https://www.skyquestt.com/speak-with-analyst/mhealth-market
mHealth Market Insight

Drivers:

  1. Increasing demand for wireless devices such as smartphones
  2. Growing penetration of 4G & 5G networks to ensure uninterrupted healthcare
  3. Increasing patient centric emphasis and healthcare delivery

Restraints:

  1. Difficulty in implementing and integrating mHealth apps
  2. Resistance from traditional healthcare providers & limited guidance from physicians
  3. Lack of data security and concerns regarding data theft and healthcare fraud

Prominent Players in mHealth Market
The following are the Top mHealth Companies

  • Koninklijke Philips N.V. (Netherlands)
  • Medtronic plc (Ireland)
  • Johnson & Johnson (US)
  • Omron Healthcare Co., Ltd. (Japan)
  • Cerner Corporation (US)
  • Apple, Inc. (US)
  • AliveCor, Inc. (US)
  • AirStrip Technologies (US)
  • athenahealth, Inc. (US)
  • iHealth Lab Inc. (US)

View Report Summary and Table of Contents (TOC):
https://www.skyquestt.com/report/mhealth-market

Key Questions Answered in Global mHealth Market Report

  • What is the estimated market size for mHealth globally by 2031, and what is the anticipated compound annual growth rate (CAGR) for the 2024–2031 projection period?
  • In the global mHealth market, which region generated the most revenue in 2021, and what factors led to this?
  • Which are the main factors propelling the global mHealth market expansion?

This report provides the following insights:

  • Analysis of key drivers (Increased global demand for smartphones, variety of healthcare-related services, rising desire for better communication & information and increased communication capabilities in Hospital Information Systems), restraints (Complexity of integration & implementation, usability of mHealth to be as simple as possible and lack of guidance or support from doctors towards the technology), opportunities (Remote healthcare solutions leveraging advanced telecommunication technologies, smartphone-linked solutions and remote health monitoring or consultation services), and challenges (Security concerns about proprietary data & applications and no standard frameworks to secure data stored) influencing the growth of mHealth market
  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the mHealth market
  • Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the mHealth market
  • Market Development: Comprehensive information on lucrative emerging regions
  • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the market
  • Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.

Related Reports:

Healthcare IT Market

Digital Health Market

Artificial Intelligence (AI) in Healthcare Market

Home Healthcare Market

Telemedicine Market

About Us:

SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology. 

We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization has expanded our reach across North America, Europe, ASEAN and Asia Pacific.

Contact:

Mr. Jagraj Singh

Skyquest Technology

1 Apache Way,

Westford,

Massachusetts 01886

USA (+1) 351-333-4748

Email: sales@skyquestt.com

Visit Our Website: https://www.skyquestt.com/

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.